每周股票复盘：爱博医疗（688050）拟控股德美医疗

Core Viewpoint - Aibo Medical (688050) is planning to acquire at least 51% of the shares of Demei Medical, aiming to gain control over the company, which is a leading player in the domestic sports medicine sector [1] Company Announcement Summary - Aibo Medical signed a letter of intent on January 20, 2026, with Demei United (Chongqing) Medical Technology Co., Ltd. and its founder Li Jianbo to acquire at least 51% of Demei Medical's shares through a combination of acquisition loans and self-funding [1] - Demei Medical is recognized as a national high-tech enterprise and a "specialized, refined, and innovative" small giant enterprise, holding 276 patents and covering the entire chain from preoperative prevention to surgical treatment and postoperative rehabilitation [1] - The transaction is subject to due diligence, formal agreement signing, and internal approval processes, and currently serves as a preliminary intention without legal binding force, except for confidentiality and exclusivity clauses [1]